(Q42259672)

19 October 2017

Endocarditis caused by resistant enterococcus: an overview (English)

1 reference

19 October 2017

Katherine Reyes

1

1 reference

PubMed ID

23749322

19 October 2017

Marcus Zervos

series ordinal

2

1 reference

19 October 2017

1 August 2013

1 reference

Current infectious disease reports

19 October 2017

1 reference

19 October 2017

15

1 reference

19 October 2017

4

1 reference

19 October 2017

320-328

1 reference

Emergence and management of drug-resistant enterococcal infections

19 October 2017

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Clinical relevance of the ESKAPE pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

The global spread of healthcare-associated multidrug-resistant bacteria: a perspective from Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Enterococcal endocarditis on native and prosthetic valves: a review of clinical and prognostic factors with emphasis on hospital-acquired infections as a major determinant of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Enterococcal endocarditis in Sweden, 1995-1999: can shorter therapy with aminoglycosides be used?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Enterococcal endocarditis: can we win the war?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Evaluation of risk factors for coinfection or cocolonization with vancomycin-resistant enterococcus and methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Incidence of and risk factors for infection or colonization of vancomycin-resistant enterococci in patients in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

The epidemiology of vancomycin-resistant Enterococcus colonization in a medical intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Virulence and antimicrobial resistance in clinical Enterococcus faecium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Heteroresistance to vancomycin in Enterococcus faecium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Clinical and microbiological characteristics of vancomycin-resistant enterococci with the VanD phenotype and vanA genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Linezolid surveillance results for the United States: LEADER surveillance program 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Quinupristin-dalfopristin resistance in gram-positive bacteria: mechanism of resistance and epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Daptomycin exposure precedes infection and/or colonization with daptomycin non-susceptible enterococcus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Failure of daptomycin monotherapy for endocarditis caused by an Enterococcus faecium strain with vancomycin-resistant and vancomycin-susceptible subpopulations and evidence of in vivo loss of the vanA gene cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Virulence factors in isolates of Enterococcus faecalis from infective endocarditis and from the normal flora

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Single center experience of a vancomycin resistant enterococcal endocarditis cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Molecular epidemiology of vancomycin-resistant enterococcal bacteraemia: results from the Canadian Nosocomial Infection Surveillance Program, 1999-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Observational study of the epidemiology and outcomes of vancomycin-resistant Enterococcus bacteraemia treated with newer antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Infections associated with ventricular assist devices: epidemiology and effect on prognosis after transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Unmet needs and prospects for oritavancin in the management of vancomycin-resistant enterococcal infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Outcomes Associated With Vancomycin-Resistant Enterococci: A Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Endocarditis due to vancomycin-resistant enterococci: case report and review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Treatment of streptomycin-susceptible and streptomycin-resistant enterococcal endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

DNA persistence and relapses questions on the treatment strategies of Enterococcus infections of prosthetic valves

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Efficacy of the combination ampicillin plus ceftriaxone in the treatment of a case of enterococcal endocarditis due to Enterococcus faecalis highly resistant to gentamicin: efficacy of the "ex vivo" synergism method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Success of ampicillin plus ceftriaxone rescue therapy for a relapse of Enterococcus faecalis native-valve endocarditis and in vitro data on double beta-lactam activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Combination therapy with ampicillin and daptomycin for treatment of Enterococcus faecalis endocarditis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Successful treatment of persistent bacteremia due to vancomycin-resistant, ampicillin-resistant Enterococcus faecium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Treatment of vancomycin-resistant enterococcus with quinupristin/dalfopristin and high-dose ampicillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Endocarditis due to Vancomycin-resistant Enterococcus faecium in an Immunocompromised Patient: Cure by Administering Combination Therapy with Quinupristin/Dalfopristin and High-dose Ampicillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Successful treatment of persistent vancomycin-resistant Enterococcus faecium bacteremia with linezolid and gentamicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Treatment of prosthetic valve infective endocarditis due to multi-resistant Gram-positive bacteria with linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Linezolid as rescue treatment for left-sided infective endocarditis: an observational, retrospective, multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Microbiology of drugs for treating multiply drug-resistant Gram-positive bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Multidrug-resistant Enterococcus faecium endocarditis treated with combination tigecycline and high-dose daptomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Relapse of enterococcal prosthetic valve endocarditis with aortic root abscess following treatment with daptomycin in a patient not fit for surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Infective endocarditis caused by daptomycin-resistant Enterococcus faecalis: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Ampicillin enhances daptomycin- and cationic host defense peptide-mediated killing of ampicillin- and vancomycin-resistant Enterococcus faecium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Evaluation of standard- and high-dose daptomycin versus linezolid against vancomycin-resistant Enterococcus isolates in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Novel antimicrobial agents against multi-drug-resistant gram-positive bacteria: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

In vitro activity of telavancin and comparators against selected groups of Gram-positive cocci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Activity of oritavancin against methicillin-resistant staphylococci, vancomycin-resistant enterococci and β-haemolytic streptococci collected from western European countries in 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

In vivo activity of a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, ceftaroline, against vancomycin-susceptible and -resistant Enterococcus faecalis strains in a rabbit endocarditis model: a comparative study with linezolid a

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Efficacy of teicoplanin, administered in two different regimens, in the treatment of experimental endocarditis due to Enterococcus faecalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

The optimal aminoglycoside and its dosage for the treatment of severe Enterococcus faecalis infection. An experimental study in the rabbit endocarditis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

A new approach of real time polymerase chain reaction in detection of vancomycin-resistant enterococci and its comparison with other methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. a prospective multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Duration of colonization and risk factors for prolonged carriage of vancomycin-resistant enterococci after discharge from the hospital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Low risk of apparent transmission of vancomycin-resistant Enterococci from bacteraemic patients to hospitalized contacts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

The effectiveness of a single-stage versus traditional three-staged protocol of hospital disinfection at eradicating vancomycin-resistant Enterococci from frequently touched surfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Impact of chlorhexidine-impregnated washcloths on reducing incidence of vancomycin-resistant enterococci colonization in hematology-oncology patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Vancomycin resistant enterococci: from the hospital effluent to the urban wastewater treatment plant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Contemporary Epidemiology and Prognosis of Health Care–Associated Infective Endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Ampicillin Plus Ceftriaxone Is as Effective as Ampicillin Plus Gentamicin for TreatingEnterococcus faecalisInfective Endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0348-Y

Risk factors for infective endocarditis in patients with enterococcal bacteremia: a case-control study

21 January 2018

1 reference

12 December 2020

Characterization of Enterococcus faecium isolates and first report of vanB phenotype-vanA genotype incongruence in the Middle East

1 reference

12 December 2020

High-level gentamicin resistance in Enterococcus: microbiology, genetic basis, and epidemiology

1 reference

12 December 2020

Editorial Commentary: Enterococcus faecalis infective endocarditis: is it time to abandon aminoglycosides?

1 reference

12 December 2020

Effective treatment of multidrug-resistant enterococcal experimental endocarditis with combinations of cell wall-active agents

1 reference

12 December 2020

Enterococcal bloodstream infection after hematopoietic stem cell transplant: experience of a center with a low prevalence of vancomycin-resistant enterococci

1 reference

12 December 2020

Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides

1 reference

12 December 2020

Association between the presence of enterococcal virulence factors gelatinase, hemolysin, and enterococcal surface protein and mortality among patients with bacteremia due to Enterococcus faecalis

1 reference

12 December 2020

High-dose daptomycin for treatment of complicated gram-positive infections: a large, multicenter, retrospective study

1 reference

12 December 2020

In vitro activity of daptomycin & linezolid against methicillin resistant Staphylococcus aureus & vancomycin resistant enterococci isolated from hospitalized cases in Central India.

1 reference

12 December 2020

Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997-1999.

1 reference

12 December 2020

A surveillance of high-level gentamicin-resistant enterococcal bacteremia

1 reference

12 December 2020

Comparative in vitro and bactericidal activity of oxazolidinone antibiotics against multidrug-resistant enterococci

1 reference

12 December 2020

[Comparative study of treatment with quinupristin-dalfopristin alone or in combination with gentamicin, teicoplanin, imipenem or levofloxacin in experimental endocarditis due to a multidrug-resistant Enterococcus faecium]

1 reference

12 December 2020

Vancomycin-resistant Enterococcus faecium (VRE) bacteremia in infective endocarditis successfully treated with combination daptomycin and tigecycline

1 reference

12 December 2020

Enterococcal endocarditis: 107 cases from the international collaboration on endocarditis merged database

1 reference

12 December 2020

A liaF codon deletion abolishes daptomycin bactericidal activity against vancomycin-resistant Enterococcus faecalis

1 reference

12 December 2020

Problems and perils of vancomycin resistant enterococci

1 reference

12 December 2020

Isolation and molecular characterization of vancomycin-resistant Enterococcus faecium from swine in Michigan, USA.

1 reference

12 December 2020

10.1007/S11908-013-0348-Y

Identifiers

DOI

1 reference

19 October 2017

1 reference

PubMed ID

23749322